Skip to main content

Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 31st Annual Global Healthcare Conference on Thursday, November 10th, 2022 at the Terranea Resort in Rancho Palos Verdes, CA. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 12:50 p.m. (Eastern Time).

This audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48 hours after the live webcast.

Contacts

Press Contact:



Linda Fedow

(732) 524-6071



Investor Contact:



Raychel Kruper

(732) 524-6164

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.76
-0.56 (-0.22%)
AAPL  269.11
-0.93 (-0.34%)
AMD  257.30
+7.25 (2.90%)
BAC  52.52
-1.02 (-1.91%)
GOOG  284.74
+6.68 (2.40%)
META  638.99
+11.67 (1.86%)
MSFT  507.28
-7.05 (-1.37%)
NVDA  198.01
-0.68 (-0.34%)
ORCL  251.44
+3.27 (1.32%)
TSLA  460.88
+16.62 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.